Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,003 USD | -.--% |
|
-.--% | -.--% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01-01-09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05-12-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
President | 68 | 01-01-09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05-12-19 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 51 000 | 0 | 0 | 18,04 % |
Aandeel B | 1 | 434 514 578 | 78 406 578 ( 18,04 %) | 0 |
Bedrijfsgegevens
Nunzia Pharmaceutical Corp.
1627 West 14th Street
90813, Long Beach
+714 609 9117
![Adres Nunzia Pharmaceutical Company(NUNZ)](https://cdn.zonebourse.com/static/address/111313488.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 1,3 mln. | |
+54,61% | 811 mld. | |
+43,70% | 640 mld. | |
-6,33% | 353 mld. | |
+20,62% | 333 mld. | |
+10,44% | 302 mld. | |
+17,70% | 246 mld. | |
+2,41% | 225 mld. | |
+12,94% | 218 mld. | |
+8,61% | 168 mld. |
- Beurs
- Aandelen
- Koers NUNZ
- Onderneming Nunzia Pharmaceutical Company